undamentalytics Newsletter

Trulieve Cannabis Corp. insider trading

Every open-market purchase and sale by Trulieve Cannabis Corp.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No insider has bought shares on the open market in five years.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
Trulieve Cannabis Corp. insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Trulieve Cannabis Corp.’s insiders pay?

From May 19, 2021 to December 13, 2024, 14 insiders reported 21 open-market purchases and 1 sale not made under a pre-set plan in Trulieve Cannabis Corp. Twelve months after each purchase was reported, the shares were −45.7% against the S&P 500 on average (median −52.3%), over 20 purchases with a full year of prices; 5% beat the index. After sales, the shares moved −74.7% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on May 20, 2021 into $2,728 by November 2, 2026, −21.3% a year. It held shares 71% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $15,801 (+8.8% a year), and held throughout $19,603 (+13.2%).

$0$10.0k$20.0k 202120222023202420252026 $19.6k$15.8k$2.7k
Copying Trulieve Cannabis Corp.'s insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by Trulieve Cannabis Corp.'s insiders from May 20, 2021, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 71% of the time.
Trulieve Cannabis Corp.: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Rivers Kim A. Chairman and CEO 5 −30.9% (5) 20% 0 — November 18, 2024
D'amico Alex Chief Financial Officer 3 −62.7% (3) 0% 0 — May 25, 2022
Landrum Kyle Chief Production Officer 2 −54.7% (2) 0% 0 — November 13, 2024
Thronson Susan Director 2 −40.5% (2) 0% 0 — November 21, 2024
Alvarez Giannella Director 0 — — 1 −74.7% (1) May 20, 2024
Beshears Thad Director 1 −28.3% (1) 0% 0 — November 19, 2024
Getman Wes Chief Financial Officer 1 — — 0 — December 13, 2024
Healy Peter Director 1 −24.0% (1) 0% 0 — November 21, 2024
Jhala Nilyum Chief Technology Officer 1 −44.5% (1) 0% 0 — November 14, 2024
Millner Thomas L Director 1 −24.0% (1) 0% 0 — November 21, 2024
Morey Timothy Chief Sales Officer 1 −75.9% (1) 0% 0 — May 25, 2022
Powers Eric GC and Corporate Secretary 1 −75.9% (1) 0% 0 — May 25, 2022
White Steven Matthew President 1 −75.9% (1) 0% 0 — May 25, 2022
Zhang Marie Chief Operating Officer 1 −33.5% (1) 0% 0 — November 13, 2024

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded Trulieve Cannabis Corp.

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Trulieve Cannabis Corp. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 3 buying crowds with six months of prices, it averaged −27.8% against the index. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
November 29, 20248 buying−23.0%−33.0%−15.9%
May 31, 20226 buying−0.5%−8.9%−76.3%
June 30, 20213 buying−30.1%−41.6%−58.7%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

← Back to Trulieve Cannabis Corp. · Funds · Politicians